Veradermics, Incorporated
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MANE | KRYS | VRCA | PTGX | PVLA | TARS | |
|---|---|---|---|---|---|---|
| Market cap | 5.70B | 9.21B | 59.35M | 9.28B | 2.34B | 3.23B |
| P/E (TTM) | — | 42.2 | — | 139.2 | — | — |
| Forward P/E | -51.8 | 34.0 | -2.8 | -1,444.4 | -20.5 | -138.1 |
| Price/book | 7.0 | 6.4 | 13.8 | 11.0 | 10.8 | 32.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +261.62% | +55.44% | −3.49% | +80.07% | +106.38% | +1.44% |
| Today | +2.17% | +1.90% | +5.02% | +2.23% | +6.11% | −4.91% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All MANE news ›Veradermics announces phase 3 results for oral minoxidil for hair loss
Veradermics, a pharma company focused on developing innovative therapeutics for pattern hair loss, has announced positive phase 3 results for its oral minoxidil formulation for mild-to-moderate pattern hair loss. Study ‘304’ evaluated…
Verano Holdings remains undervalued, this analyst says
On Oct. 29, Haywood Securities analyst Neal Gilmer maintained his “Buy” rating and C$18.75 target on Verano Holdings (Verano Holdings Stock Quote, Chart, News, Analysts, Financials NEO:VRNO) following third-quarter results that fell short…
Veradermics (NYSE:MANE) Sets New 12-Month High – What’s Next?
Posted by Sarita Garza on Oct 24th, 2026 Shares of Veradermics, Incorporated (NYSE:MANE – Get Free Report) hit a new 52-week high during trading on Thursday. The stock traded as high as $139.12 and last traded at $137.0790, with a volume…
Veradermics, Incorporated (NYSE:MANE) Stock Has Average Price Target of $153.00
Posted by Danessa Lincoln on Oct 23rd, 2026 View Our Latest Stock Report on Veradermics Shares of NYSE MANE opened at $138.90 on Friday. Veradermics has a twelve month low of $32.00 and a twelve month high of $141.75. The firm has a fifty…
Disc’s redemption, China’s rise, Veradermics’ validation, ESMO’s headliners
> Listen on Spotify > Listen on Apple Products > Listen on Amazon Music > Listen on iHeart > Watch on YouTube M&A deals are rare for Chinese sellers, with 91% of all deals so far this year coming from U.S.-based companies. BioSpace Senior…
Veradermics, Incorporated (MANE) Discusses Positive Top Line Results From Phase III Study 304 of VDPHL01 in Male Pattern Hair Loss - Slideshow
2026-10-21. The following slide deck was published by Veradermics, Incorporated in conjunction with this event. The following slide deck was published by Veradermics, Incorporated in conjunction with this event.
Veradermics to discuss Phase 3 ‘304’ topline results on call
Veradermics announced it will host a conference call and live webcast on 19 October 2026 at 8:00 am ET to review Part A topline results from its randomized, double-blind, placebo-controlled phase 3 study 304 evaluating VDPHL01 in 536 males…
Veradermics' Oral Hair-Loss Pill Clears Late-Stage Trial
The first pill for pattern baldness in almost 30 years is edging toward market after a successful late-stage readout. Veradermics, based in New Haven, Connecticut, said its candidate VDPHL01 hit the trial's key measures in 536 men with…
Veradermics’ oral hair-loss drug shown to boost hair growth in late-stage study
Oct 19 (Reuters) – Drug developer Veradermics said on Monday that its oral pill helped increase hair growth in men with pattern hair loss in a late-stage study. • The company was testing its oral minoxidil formulation, called VDPHL01, in…
Veradermics scores another late-stage trial win for hair loss therapy
Veradermics (MANE) stock gains after another late-stage trial win for the company's hair loss therapy, VDPHL01. Read more here. Veradermics (MANE) gained in early premarket trading on Monday after announcing that another late-stage trial…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com9
- defenseworld.net3
- seekingalpha.com3
- biospace.com2
- marketbeat.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 27 articles, not a forecast.